top of page
Search

First-in-Canada testing program for Alzheimer’s

Updated: Dec 26, 2021

On July 1, 2021 the St. Paul's Hospital Clinical Laboratory in Vancouver launched the Alzheimer's disease biomarker testing program for all Canadians.


Read the story here:


This first-in-Canada program was made possible via the IMPACT-AD study. The IMPACT-AD British Columbia and IMPACT-AD Canada studies were launched to help Canadians develop a comprehensive understanding of how Alzheimer’s disease biomarker testing impacts medical and personal decision making, and health care costs. The goal of IMPACT-AD is to inform positive change in the Canadian health care system to improve care and support for individuals living with Alzheimer’s disease, and their families.



 
 
Address
 

St. Paul's Hospital

Dept of Pathology & Laboratory Medicine

1081 Burrard St, Vancouver Canada, V6Z 1Y6

Connect

Web: www.DeMarcoLab.ca

Email: mari.demarco [at] ubc.ca

canada-flag-bw.jpg

© 2020 M.L.DeMarco

bottom of page